Special Issue "Scientific Highlights in the First European Paediatric Translational Research Infrastructure Open Meeting"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: 31 December 2021.
Interests: drug delivery; drug targeting; TSPO; imaging; tumors
Special Issues and Collections in MDPI journals
Special Issue in International Journal of Molecular Sciences: Translocator Protein (TSPO) in Drug Delivery and Imaging of Pathological Disorders
Special Issue in International Journal of Molecular Sciences: Paediatric Formulation: Design and Development
Special Issue in International Journal of Molecular Sciences: Paediatric Formulation: Design and Development 2.0
Special Issue in International Journal of Molecular Sciences: Imaging and Treating Tumors Overexpressing TSPO
It is a great pleasure to announce the opening of a Special Issue dedicated to highlight the European Paediatric Translational Research Infrastructure (EPTRI) open meeting (https://www.cvbf.net/eptri/).
EPTRI is an EU-funded project aimed to design the framework for a new infrastructure dedicated to paediatric research that will work to accelerate paediatric drug development, from the discovery of drugs and the definition of biomarkers and biosamples to developmental pharmacology and age-tailored formulations and medical devices. The final goal is to facilitate the translation of new knowledge and scientific innovations into paediatric research and activities underpinning paediatric clinical studies.
EPTRI involves partners from EU and non-EU countries, including non-profit research organisations, top-level universities, scientific and clinical centers of excellence. According to the survey conducted to map paediatric research facilities and competences, more than 300 research units declared their availability to provide technologies, services and paediatric expertise and have been grouped in the following Thematic Research Platforms: Paediatric Medicines Discovery, Paediatric Biosamples and Biomarkers, Developmental Pharmacology, Paediatric Medicines Formulations and Medical Devices.
This Special Issue is addressed to all researchers and partners involved in the development of paediatric medicines.
We welcome original research articles, reviews, opinion papers, editorials or short communications on the following topics:
- paediatric medicines drug targets and methods of identification;
- advanced cellular/in vitro models for paediatric drug targeting;
- paediatric formulations and toxicology of drugs;
- drug delivery design in paediatrics;
- translational research.
Prof. Dr. Nunzio Denora
Dr. Rosa Maria Iacobazzi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- paediatric formulations
- drug targets
- drug delivery
- translational research